Vori Health Secures $53 Million to Broaden Access to Physician-Led Musculoskeletal Care

Vori Health, a physician-led provider focused on musculoskeletal care, has raised $53 million in a Series B funding round, with NEA leading the investment. The round also saw participation from AlleyCorp, Intermountain Ventures, Echo Health Ventures, and Max Ventures. The company plans to use the funding to expand its risk-based care model, enhance its AI technology platform, and strengthen partnerships with national employers and health plans.

In the last 18 months, Vori Health has experienced significant financial and clinical developments, including an 800% increase in revenue. The company’s approach has been associated with measurable reductions in surgical interventions, prescription opioid use, and mental health conditions among patients receiving care. According to company data, 91.6% of patients reported clinically significant pain relief, and elective orthopedic surgeries were reduced by 78% to 90%, while opioid use declined by 42%. In addition, there was a reported decrease of up to 68% in depression and anxiety levels among those undergoing treatment through Vori's programs.

The fragmented nature of the musculoskeletal care system in the United States often leads to excessive treatment, high costs, and inconsistent outcomes. Vori Health aims to address these issues by offering a more integrated and streamlined model that combines virtual and in-person care. The company’s care teams include board-certified physicians, physical therapists, dietitians, and health coaches, aiming to deliver evidence-based and patient-centered treatment pathways.

Co-founder and CEO Dr. Ryan Grant stated that the investment represents “a pivotal moment” for the company as it scales its value-based care services. He emphasized the importance of combining “board-certified specialty physicians, cohesive care teams, and cutting-edge technology” to improve outcomes at the national level.

The newly secured capital will support the company’s efforts to refine its AI platform, enhance its data analytics for identifying high-risk populations, and expand population health risk models. The funding will also help deepen engagement with Fortune 200 companies and large health plans that have started to adopt the company’s services.

According to NEA Co-CEO Mohamad Makhzoumi, Vori Health stands out in a competitive market due to its physician-led model and clinical effectiveness. He noted that the company is becoming “a pioneering leader in value-based musculoskeletal care,” reinforcing NEA's commitment to the partnership.

Health plan executives have echoed similar views, citing musculoskeletal conditions as a major cost factor. One executive described the collaboration with Vori Health as one of their “best strategic decisions,” underlining the practical impact of the company’s approach on overall healthcare spending.

Founded by surgeons from Yale and the Mayo Clinic, Vori Health has built the first nationwide, physician-led platform for delivering integrated musculoskeletal care. The company’s long-term objective is to provide scalable, coordinated care that reduces unnecessary interventions while improving quality and accessibility for patients across the country.